Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient

Chinese Journal of Cancer

Volumn 31, Issue 1, 2012, Pages 36-44

  Dong, Ju Qin ^a   Li, Man Zhi ^a   Liu, Zhi Gang ^a   Zhong, Qian ^a   Xiong, Dan ^a   Xu, Li Hua ^a   Du, Yong ^a   Xia, Yun Fei ^a   Zeng, Mu Sheng ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Epstein Barr virus; Nasopharyngeal carcinoma; SUNE2 cell line

Indexed keywords

BAMH1A RIGHT FRAME 1 PROTEIN; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESEARCH; CELL GROWTH; CELL TRANSFORMATION; CHINESE; COLONY FORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION;

ADULT; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLONY-FORMING UNITS ASSAY; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; RNA, VIRAL; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 84862965966     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10317     Document Type: Article

References (21)

1. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer, 2011,30 (2):114-119.
2. Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol, 2008,39(4):473-483.
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med, 2000,343 (7):481-492.
4. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol, 2002,12(6):431-441.
5. Stevens SJ, Verkuijlen SA, Hariwiyanto B, et al. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer, 2006,119 (3):608-614.
6. Bell AI, Groves K, Kelly GL, et al. Analysis of Epstein-Barr virus latent gene expression in endemic burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol, 2006,87(Pt 10): 2885-2890.
7. Brooks L, Yao QY, Rickinson AB, et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol, 1992,66(5):2689-2697.
8. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer, 2004,4(10):757-768.
9. Gullo C, Low WK, Teoh G. Association of Epstein-Barr virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines. Ann Acad Med Singapore, 2008,37(9):769-777.
10. Cheung ST, Huang DP, Hui AB, et al. Nasopharyngeal carcinoma cell line (c666-1) consistently harbouring Epstein-Barr virus. Int J Cancer, 1999,83(1):121-126.
11. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell, 2004,5(5):423-428.
12. Yao KT, Zhang HY, Zhu HC, et al. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer, 1990,45(1):83-89.
13. Glaser R, Zhang HY, Yao KT, et al. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A, 1989,86(23):9524-9528.
14. Chang YS, Lin SY, Lee PF, et al. Establishment and characterization of a tumor cell line from human nasopharyngeal carcinoma tissue. Cancer Res, 1989,49 (23): 6752-6757.
15. Hui AB, Cheung ST, Fong Y, et al. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. Cancer Genet Cytogenet, 1998,101(2):83-88.
16. Teng ZP, Ooka T, Huang DP, et al. Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes, 1996,13(1):53-60.
17. Weber AL, al-Arayedh S, Rashid A. Nasopharynx: clinical, pathologic, and radiologic assessment. Neuroimaging Clin N Am, 2003,13(3):465-483.
18. Kieff E. Epstein-Barr virus-increasing evidence of a link to carcinoma. N Engl J Med, 1995,333(11):724-726.
19. Busson P, Ganem G, Flores P, et al. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer, 1988,42 (4):599-606.
20. Gazzolo L, De-The G, Vuillaume M, et al. Nasopharyngeal carcinoma. Ii. Ultrastructure of normal mucosa, tumor biopsies, and subsequent epithelial growth in vitro. J Natl Cancer Inst, 1972,48(1):73-86.
21. Chow KC, Ma J, Lin LS, et al. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D. Cancer Epidemiol Biomarkers Prev, 1997,6(5):363-368.